| Julea Smalenberg, | |
|
11522 E 26th Ln, Yuma, AZ 85367-4938 | |
| (928) 246-5965 | |
| Not Available |
| Full Name | Julea Smalenberg |
|---|---|
| Gender | Female |
| Speciality | Occupational Therapist |
| Location | 11522 E 26th Ln, Yuma, Arizona |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1336574805 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225X00000X | Occupational Therapist | 314029 (Arizona) | Primary |
| Provider Name | Theraplay4kidz, Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1750727798 PECOS PAC ID: 3476823972 Enrollment ID: O20190321000727 |
News Archive
Exposure to tobacco smoke - even occasional smoking or secondhand smoke - causes immediate damage to your body that can lead to serious illness or death, according to a report released today by U.S. Surgeon General Regina M. Benjamin. The comprehensive scientific report - Benjamin's first Surgeon General's report and the 30th tobacco-related Surgeon General's report issued since 1964 - describes specific pathways by which tobacco smoke damages the human body and leads to disease and death.
The interim data, from 205 volunteers in clinical trials in Kenya, Uganda and the United Kingdom, show that DNA.HIVA and MVA.HIVA are generally safe and well tolerated. However, the candidates' ability to elicit an anti-HIV cell-mediated immune response is poor, using currently accepted measures of immune response.
Located at Vancouver General Hospital and a partner of the BC Cancer Agency, the Genetic Pathology Evaluation Centre, led by three prominent pathologists, is a recognized world leader in cancer research in the area of biomarker technology. Today, with an additional unrestricted grant of $250,000 from sanofi-aventis, GPEC is ready to make even more scientific breakthroughs.
The U.S. Food and Drug Administration today approved raxibacumab injection to treat inhalational anthrax, a form of the infectious disease caused by breathing in the spores of the bacterium Bacillus anthracis. Raxibacumab also is approved to prevent inhalational anthrax when alternative therapies are not available or not appropriate.
ITelagen, a leading provider of electronic health record hosting and management announced that it was selected by Manhattan's Physician Group to host, support and manage EHR for their medical practice. The newly provided solution includes hosting of patient data in ITelagen's SAS-70 Type II certified datacenter and an extension of ITelagen's support agreement that provides unlimited IT support for staff members.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Julea Smalenberg, 11522 E 26th Ln, Yuma, AZ 85367-4938 Ph: (928) 246-5965 | Julea Smalenberg, 11522 E 26th Ln, Yuma, AZ 85367-4938 Ph: (928) 246-5965 |
News Archive
Exposure to tobacco smoke - even occasional smoking or secondhand smoke - causes immediate damage to your body that can lead to serious illness or death, according to a report released today by U.S. Surgeon General Regina M. Benjamin. The comprehensive scientific report - Benjamin's first Surgeon General's report and the 30th tobacco-related Surgeon General's report issued since 1964 - describes specific pathways by which tobacco smoke damages the human body and leads to disease and death.
The interim data, from 205 volunteers in clinical trials in Kenya, Uganda and the United Kingdom, show that DNA.HIVA and MVA.HIVA are generally safe and well tolerated. However, the candidates' ability to elicit an anti-HIV cell-mediated immune response is poor, using currently accepted measures of immune response.
Located at Vancouver General Hospital and a partner of the BC Cancer Agency, the Genetic Pathology Evaluation Centre, led by three prominent pathologists, is a recognized world leader in cancer research in the area of biomarker technology. Today, with an additional unrestricted grant of $250,000 from sanofi-aventis, GPEC is ready to make even more scientific breakthroughs.
The U.S. Food and Drug Administration today approved raxibacumab injection to treat inhalational anthrax, a form of the infectious disease caused by breathing in the spores of the bacterium Bacillus anthracis. Raxibacumab also is approved to prevent inhalational anthrax when alternative therapies are not available or not appropriate.
ITelagen, a leading provider of electronic health record hosting and management announced that it was selected by Manhattan's Physician Group to host, support and manage EHR for their medical practice. The newly provided solution includes hosting of patient data in ITelagen's SAS-70 Type II certified datacenter and an extension of ITelagen's support agreement that provides unlimited IT support for staff members.
› Verified 1 days ago
Carrie Sue Edwards, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 450 W 6th St, Yuma, AZ 85364 Phone: 928-502-4300 | |
Paul P Mendiola, OT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1951 W 25th St, Suite C, Yuma, AZ 85364 Phone: 928-726-7900 Fax: 928-726-7901 | |
Romariz Lizardo, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 901 W 24th St, Yuma, AZ 85364 Phone: 928-726-5000 | |
Rishi Bamba, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 4109 S Saltbush Ave, Yuma, AZ 85365 Phone: 928-723-5226 | |
Lauri Ann Stumph, OT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1380 S Castle Dome Ave Ste 104, Yuma, AZ 85365 Phone: 928-605-7070 | |
Holly D Jordan, OTR/L Occupational Therapist Medicare: Medicare Enrolled Practice Location: 2244 S Avenue A Ste E, Yuma, AZ 85364 Phone: 928-782-5588 Fax: 928-782-5755 | |
Mr. Christopher Smith, OTR/L Occupational Therapist Medicare: Accepting Medicare Assignments Practice Location: 11274 S Fortuna Rd, Suite I-3, Yuma, AZ 85367 Phone: 928-726-0091 Fax: 928-726-0092 |